Overview

Rivastigmine and Huperzine A as Treatments for Cocaine Dependence

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effects of rivastigmine and huperzine A (HupA), potential treatments for cocaine abuse, when used before experimental administration of cocaine, on a number of physical and psychological measures.
Phase:
Phase 1
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Huperzine A
Rivastigmine